A recent presentation delivered to the UK Asbestos Taskforce has brought renewed attention to how the long-term health burdens of historical and environmental asbestos exposure are calculated, questioning the Health and Safety Executive’s position of a one-to-one ratio between mesothelioma and other asbestos-related deaths.
Speaking to the taskforce, Professor Daniel Murphy (Chair in Lung Cancer and Mesothelioma at the University of Glasgow) presented epidemiological correlation data and preliminary laboratory findings suggesting that the true volume of asbestos-related lung cancer cases may be significantly underrepresented by traditional estimation models. The discussion highlighted a notable geographic correlation in public health datasets between higher regional rates of mesothelioma and elevated rates of lung cancer, a trend that genomic mutation benchmarking suggests is distinct from the genetic signatures typically left by smoking. Furthermore, emerging research funded by Action on Asbestos from animal models indicates that low-level, repeated inhalation of chrysotile (white asbestos) fibres can accelerate tumour development in genetically predisposed subjects.
While these findings continue to be evaluated by the scientific and regulatory community, Professor Murphy argues that there is a significant undercount of asbestos-related lung cancer deaths across the UK.
The complete technical summary and review of the presentation can be read in full on pages 20 and 21 of the Summer 2026 Edition of ARCA News here.
Whilst causation will remain a matter for expert medical comment and the Court, we would be pleased to discuss any potential asbestos-related lung cancer cases from an engineering/occupational hygienist’s perspective, including providing an estimate of cumulative exposure. Please get in touch to arrange a call with one of our experts.